Trial intelligence / Profile preview

Insulin aspart during maintenance hemodialysis in non-diabetic end-stage renal failure

2010-020114-29Phase 4Completed

Sponsor
Department of Nephrology
Start
Jun 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of insulin aspart in end-stage kidney disease (ESKD), sponsored by Department of Nephrology. Primary endpoint: Proof-of-concept experimental endpoints. Started Jun 2010; status: completed.

02

Drugs

insulin aspart
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on 2010-020114-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020114-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call